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AbstrACt
Objective Between 2012 and 2017 dementia case finding 
was routinely carried out on people aged 75 years and 
over with unplanned admissions to acute hospitals across 
England. The assumption was that this would lead to 
better planning of care and treatment for patients with 
dementia following discharge from hospital. However, little 
is known about the experiences of patients and carers or 
the impacts on other health services. This study explored 
the impact of dementia case finding on older people and 
their families and on their use of services.
Design Thematic content analysis was conducted on 
qualitative interview data and costs associated with 
service use were estimated. Measures included the Mini-
Mental State Examination, the EuroQol quality of life scale 
and a modified Client Service Receipt Inventory.
setting Four counties in the East of England.
Participants People aged ≥75 years who had been 
identified by case finding during an unplanned hospital 
admission as warranting further investigation of possible 
dementia and their family carers.
results We carried out 28 interviews, including 19 joint 
patient-carer(s), 5 patient only and 4 family carer interviews. 
Most patients and carers were unaware that memory 
assessments had taken place, with many families not 
being informed or involved in the process. Participants had 
a variety of views on memory testing in hospital and had 
concerns about how hospitals carried out assessments and 
communicated results. Overall, case finding did not lead to 
general practitioner (GP) follow-up after discharge home or 
lead to referral for further investigation. Few services were 
initiated because of dementia case finding in hospital.
Conclusions This study shows that dementia case 
finding may not lead to increased GP follow-up or service 
provision for patients after discharge from hospital. There 
is a need for a more evidence-based approach to the 
initiation of mandatory initiatives such as case finding 
that inevitably consume stretched human and financial 
resources.
IntrODuCtIOn
Pre-existing cognitive impairment in hospi-
talised older people is estimated at between 
15% and 42%.1–5 Many of these patients 
may not have had a previous diagnosis of 
dementia.3 6 This has led to concerns about 
providing adequate care for older people 
with dementia, and policy development to 
improve the identification of dementia in 
older people in hospital.7–10 In the English 
National Health Service (NHS) initiatives 
were introduced to increase awareness and 
improve the identification of dementia 
in secondary care.11–14 In 2012–2013, the 
Department of Health introduced a manda-
tory policy requiring that all hospitals across 
England routinely carry out cognitive assess-
ments with ≥75-year olds who have had an 
emergency admission and that those iden-
tified as potentially having dementia are 
strengths and limitations of this study
 ► This is one of the first studies to investigate the im-
pacts of a mandatory policy introduced nationwide 
without prior piloting, feasibility testing or evidence 
of effectiveness—case finding for dementia among 
all hospital patients aged ≥75 years whose admis-
sion was unplanned.
 ► Qualitative research methods using topic-guided 
interviews enabled in-depth exploration of personal 
experiences of dementia case finding both during a 
hospital stay and of health and care services used 
subsequently.
 ► As the focus was on those identified by case finding 
while in-patients, the study design sought to inter-
view relatives/family carers as well as these former 
patients themselves.
 ► Study limitations include a small sample size and 
a reliance on participants’ self-reporting of service 
use data.
 ► It was beyond the scope of this study to track actual 
service use costs so our cost estimation draws on 
published unit costs data.
 o
n
 31 July 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026927 on 3 June 2019. Downloaded from 
2 Burn A-M, et al. BMJ Open 2019;9:e026927. doi:10.1136/bmjopen-2018-026927
Open access 
appropriately assessed and referred. The rationale for 
case finding in hospital was that early identification of 
cognitive impairment would lead to a timely diagnosis, 
informed patient care and improved health outcomes for 
older people.15 16 This was implemented in the absence 
of any randomised controlled trial evidence to know the 
impact of such an approach.
Although cognitive assessment tests can detect undi-
agnosed dementia,17–19 dementia does not fit the criteria 
for screening programmes and there are concerns 
over the impacts of case finding as well as screening 
for dementia.20 21 Moreover, in practice the distinction 
between screening and case finding is often not clear to 
clinicians and the public.22 23 Healthcare professionals 
have been reported as viewing case finding as a finan-
cially and politically driven policy with little or no eval-
uation of patient outcomes.24–27 In a previous paper, we 
reported how the variation in approaches to dementia 
case finding has meant that information communicated 
to primary care is inconsistent and has an impact on 
how well general practitioners (GPs) can effectively plan 
patients’ treatment and care once they are home in the 
community.27
Little is known about the wider impacts of dementia 
case finding on patient and carer experiences and on 
their access to dementia-related or other care services. 
The overall aims of this study were to explore the impacts 
of dementia case finding on older people identified by 
hospital case finding as warranting further investigation, 
their family carers and their use of health service and 
care services. For example, were they being reassessed 
in primary care and, if appropriate, receiving specialist 
referral, being given a diagnosis or receiving new services?
MethODs
This study involved in-depth exploratory interviews with 
former hospital patients and their family carers. A range 
of qualitative and quantitative data was collected. This was 
the second phase of the CASCADE study (CASe finding in 
hospitals—impacts on CAre for people with DEmentia).28 
Phase I results are reported in full elsewhere.27
We recruited former patients of two participating hospi-
tals in the East of England. Eligible patients were aged at 
least 75-year olds, had been acutely admitted 6–12 months 
previously, had been flagged by dementia case finding 
as warranting further investigation about their cogni-
tion and were community dwelling. Family carers of these 
patients were also recruited for interviews. Invitation 
letters were sent to eligible participants from the hospital 
elderly medicine consultant under whose care they had 
been admitted, together with an information sheet and 
response form.
Semistructured interview schedules were developed 
to gather patient and family carers’ experiences and 
perceptions of dementia case finding and the impacts 
of case finding on their subsequent treatment and 
care (online supplementary file 1). Demographic data 
were collected and the Mini-Mental State Examina-
tion (MMSE)29 and EuroQol (EQ-5D-5L)30 validated 
scales were used to characterise patients’ cognition and 
health-related quality of life, respectively. For the analysis, 
those with a score below 24 on the MMSE were classified 
as cognitively impaired and those with a score of 24 and 
above were categorised as cognitively intact. EuroQol’s 
validated proxy version of the EQ-5D-5L was undertaken 
with carers to characterise patients in the minority of cases 
when a carer were interviewed separately from the former 
patient. Completed EQ-5D-5Ls were scored against the 
published algorithm and results from the scale’s five 
domains were used to characterise participants’ levels 
of difficulty in each.31 Data were collected on patients’ 
self-reported use of inpatient and outpatient services, 
day activity services since the index hospital admis-
sion, community care services and current medication. 
Service use was collected using relevant sections of the 
Client Service Receipt Inventory (CSRI)32 using ‘Visio’ 
timelines33 to facilitate recall and recording of events 
such as referrals or the start of new services. Two female 
researchers (A-MB, JF) carried out the interviews in the 
patients’ and family carers’ homes across four counties 
in the East of England (Bedfordshire, Cambridgeshire, 
Essex and Hertfordshire). Interviews lasted about an 
hour. Participants gave signed consent before the inter-
view and interviews were tape recorded, transcribed and 
anonymised.
An initial thematic framework was developed by the 
research team (A-MB, FB, JF) which was informed by the 
research questions and coding a selection of transcripts. 
The codeframe and the anonymised transcripts were 
transferred into NVivo V.11 and the data analysed using 
thematic content analysis.34 This enabled the key features 
of patients’ and carers’ experiences to be elicited from 
the data. Quantitative data were entered into an Excel 
spreadsheet.
estimation of service costs 
Service use, reported by means of the modified CSRI, 
were costed using several sources. For community-based 
healthcare, we obtained cost per hour of staff time from a 
published source of unit cost data.35 Estimates of average 
contact time and the proportion of healthcare profes-
sionals time that would be spent on direct client contact 
were used to estimate a cost per contact.36 For some 
contacts respondents reported frequency rather than 
numbers of contacts, for example, three times a week. To 
convert this to numbers of contacts we required a time 
period, this was taken as the time difference between the 
date of discharge and the date of the interview. This dura-
tion therefore varied between individuals.
Costs for secondary care were obtained from NHS refer-
ences costs.37 For elective inpatient admissions, we used 
a weighted average of either elective short stays or long 
stays. This gave estimates for the costs of elective stages of 
£616 for an elective short stay and £3058 for an elective 
long stay. For non-elective admissions, again a weighted 
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average was obtained from NHS references costs, this was 
£3058 for long stays. For accident and emergency visits, a 
weighted average of £204 was used. A detailed estimate of 
the cost of memory services was available from the liter-
ature.35 This gave a cost per client of £1218. However, 
this was based on a different NHS trust and it is not clear 
how representative this would be of the service provided 
to participants in the current study. For memory-related 
drugs, a price was obtained from a published source.38 All 
costs are in UK pound sterling for the year 2015/2016. As 
the period of analysis was for 1 year only discounting was 
not used.
PAtIent AnD PublIC InvOlveMent
Two well-established patient and public involvement 
groups were involved in the study; the University of 
Hertfordshire Patient Involvement in Research Group, 
and the University of Cambridge’s Public Involvement 
in Research into Ageing and Dementia Group. Four 
members of these groups acted as a User Reference 
Group for the study. They provided feedback on the aims 
of the study, study documents such as patient information 
sheets, and commented on preliminary findings from the 
qualitative analysis.
FInDIngs
We conducted a total of 28 interviews involving 49 partic-
ipants. Of those, 24 were former patients who had been 
identified as having a concern about their memory during 
an unplanned hospital admission and 25 were carers. 
Nineteen interviews were held jointly with the patient and 
their family carer(s). All patients had received a memory 
assessment during their hospital stay which indicated that 
there was a cause for concern over their cognition which 
warranted further investigation.
Table 1 summarises descriptive characteristics of the 
former patients in our study. Both their median and 
mean age was 85 (range 79–94) and just over half (53%) 
were women. The median MMSE score was 23.0 (IQR 
16.5–26) indicating mild cognitive impairment, but there 
was considerable variation with scores ranging between 
6 and 30. Patients had considerable levels of physical 
impairment and difficulty with activities of daily living, 
for example, nearly half were unable to walk and over a 
third had severe problems washing and dressing them-
selves. The EQ-5D-5L scoring system31 can provide scores 
between 1 and −0.594. This range has anchor points 
where 1 is considered to be full health and 0 is consid-
ered to be equivalent of dead. The scoring algorithm 
allows some scores to be <0, that is, worse than dead. 
Twenty-four former patients provided a value for their 
own health state and the mean value for these individ-
uals was 0.39 (95% CI 0.25 to 0.52). There were 25 carers 
who provided a valuation of their own health with a mean 
value 0.78 (95% CI 0.69 to 0.86). For comparison, popu-
lation norms are available for those aged over 75 years 
for the EQ-5D-3L39 which give values of 0.75 and 0.71 for 
males and females, respectively. The value obtained here 
for former patients is considerably below these values.
IMPACts OF DeMentIA CAse FInDIng On servICe use
Nine people had been assessed postdischarge either in 
a memory clinic or by an old age psychiatrist but two 
of these had already been referred by their GP prior to 
hospital admission. For the seven people who had been 
referred to memory services since hospital discharge 
it was not clear whether these referrals were a result of 
hospital case finding or not. Patients referred for investi-
gation since discharge (n=7) generally had lower MMSE 
scores than those not referred (MMSE of 17 (IQR 15–22) 
versus 25 (IQR 19–26)). In the non-referred group, two 
patients had MMSE scores that indicated severe cogni-
tive impairment and five had scores indicating moderate 
cognitive impairment. Five patients who were referred 
since case finding had been started on dementia medi-
cation (eg, donepezil, memantine), but two of these had 
stopped taking this medication within a fortnight because 
of side effects.
Estimates of the costs incurred by former patients of 
dementia case finding for the period between index stay 
discharge and interview are given in table 2. We had avail-
able data for 28 former patients, 24 where the patient was 
present at interview and 4 where only a carer was present. 
Precise costing was not generally possible, so these costs 
should be taken as indicative. This group have a mean 
Table 1 Characteristics of the former patient sample
Full sample n=28
Age 
  Mean and median 85 , 85 
  Range 79–94 
% Female MMSE 53%
   Median (IQR)
  Mean (SD)
23 (16.5–26)
20.8 (6.8)
Sample with EQ-5D-5L n=24
  Severe problems walking/
unable to walk
44%
  Severe problems washing 
and dressing self/unable to 
wash & dress self
37%
  Severe problems doing 
usual activities/unable to do 
usual activities
52%
  Severe/extreme pain or 
discomfort
4%
  Severely/extremely anxious 
or depressed
15%
  EQ-5D-5L valuation 
(95% CI)
0.39 (0.25 to 0.52)
EQ-5D-5L, EuroQol; MMSE, Mini-Mental State Examination. 
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estimated cost of £5180 (95% CI £2394 to £7967) in the 
period following the index stay. There is also consider-
able uncertainty around these cost estimates as indicated 
by the CIs. The major drivers of cost were inpatient 
and outpatient services, district nursing and home care 
worker. Comparatively few costs were specifically related 
to cognitive services, apart from memory clinics and some 
spending on memory-related drugs. There was also one 
GP home visit that was specified as related to memory 
assessment.
Two main themes emerged from the qualitative analysis 
(1) attitudes and experiences of dementia case finding 
and (2) patients’ and carers’ follow-up experiences. 
Examples quotes (Q=quotes) are given in tables 3 and 4.
Attitudes and experiences of dementia case  finding
Patients and carers were often unaware that memory 
assessments had taken place during their hospital admis-
sion and, in many cases, the patient had been assessed 
alone without a family carer being present or notified 
(Q1–2). For those carers who were aware of the memory 
assessment, they lacked information about the purpose or 
outcome of the test.
Although some patients and carers did not mind having 
a memory test in hospital (Q3), others felt that it was 
inappropriate to conduct such tests when someone was 
acutely ill (Q4–6, 9–10). Some patients reported feeling 
anxious about answering the memory questions incor-
rectly (Q7, Q8). There were examples of poor practice 
in terms of the way the test had been administered, such 
Table 2 Estimated service use cost since discharge from 
hospital
Service category Mean cost 95% CI
Inpatient stays £699 £47 to £1351
Outpatient visits £767 –£113 to £1646
Day service use £116 –£37 to £269
Community care 
contacts
£3539 £1419 to £5658
Cost of memory-
related drug
£60 –£16 to £136
Total £5180 £2394 to £7967
Table 3 Quotes illustrating theme 1
Quote Views and experiences of dementia case finding
1 I think someone did come to see him but they didn’t see me. (Carer 16)
2 I don't think that was on his release papers neither 'cos they usually put things that he's had done on his release 
papers. (Carer 04)
3 Didn’t worry me one bit. (Patient 21)
4 …if there’s no medication or they’re not going to put you on treatment what’s the point. That’s my view. (Carer 03)
5 I thought it very inappropriate when somebody’s in and they’re feeling really rough, their breathing is dreadful, full of 
pneumonia and all the rest of it (Carer 08)
6 at two o'clock in the morning… We'd been in A&E for hours…They decided that Dad should stay because he had an 
infection, and they gave him the memory test…I remember saying, ‘You are having a laugh’. (Carer 26)
7 you feel as though they’re encroaching on your brain to try and make you make a mistake, that’s how I felt. (Patient 
05)
8 [about the test] …he was shattered, and I think he was frightened. (Carer 26)
9 I would have thought that if there were to be any benefit gained it would be once the patient is stable. At admission, 
everything's frightening, worrying, they don't know what they're there for maybe or they're worried about what they're 
there for. (Carer 23)
10 I explained it, she’s more aware at home, I explained how bad she was in hospital to how different she is at home. 
(Carer 02)
11 …doctor came in and she asked [patient] some questions and of course [patient] just doesn’t always understand 
because it’s the comprehension isn’t it, cognitive as well, and so [patient] said, ‘ask my wife’, and she said, ‘I am 
asking you’ [said in an abrupt manner] which made me prickle so I said, ‘well, [patient]’s dysphasic and you know, he 
does have difficulty…and I was really cross about that, I thought time and place’. (Carer 08)
12 Well I was a little bit confused really over the whole thing, you know, well I think the family were really. (Carer 01)
13 I think they were just telling me that I had to get her to the doctors, to organise the Memory Clinic, I’m sure that’s 
what it was, they were telling me, but it wasn’t really clear, like I’m saying, I think she should have been sent home 
with some paperwork to say right, this is what is needed. (Carer 02)
14 they changed her medication and they stopped that, so there must have been a reason for stopping it…but they 
didn't tell us, we had no way of knowing until three months later, which I think is frightening. (Carer 23)
15 they were in a rush to get her out because she didn’t need any more treatment, albeit she was discharged taking 
an antibiotic and there was no indication what the antibiotic was for, or anything on the, it wasn’t included on the 
medications list. (Carer 07)
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as the test being administered in an insensitive manner 
(Q11). Even when case finding had flagged up a concern 
about a patient’s cognition this did not appear to have 
impacted on discharge planning or the involvement of 
carers (Q12, Q13). For example, patients were being 
discharged with altered medication and the hospital did 
not inform the family carers (Q14, Q15).
Patients and carers’ follow-up experiences
There was a consistent pattern for patients and relatives 
in terms of their follow-up experiences. Most reported 
that they had not had a follow-up discussion with their 
GP about the dementia case finding outcomes or reas-
sessment of their cognition postdischarge (Q16, Q17). 
Even though some had seen a GP or practice nurse since 
leaving hospital, they reported that the issue of dementia 
case finding had not been raised (Q18). Some carers 
contacted their GP about their relative’s memory but felt 
the follow-up was not always adequate (Q19–Q20). One 
carer could not understand why the hospital did not deal 
with their relative’s memory problem since they had iden-
tified it and felt this was another issue for carers to take 
on board (Q21).
Dementia case finding did not appear to have impacted 
on service provision postdischarge. Relatively few new 
services appeared to have been instigated and others, such 
as Occupational Therapy (OT) assessments and adjust-
ments to the home, were not timely. While some fami-
lies reported satisfaction with social care services, such as 
respite care (Q22), many others felt their needs were not 
being met. For example, carers coming at inappropriate 
times and the provision of poor care (Q23–Q25).
DIsCussIOn
Dementia case finding in acute hospitals involves the 
routine cognitive assessment of older people during an 
unplanned hospital stay and aims to improve the identifi-
cation of patients with dementia in hospitals so that they 
could be flagged to their GP for further investigation and 
referral. This study aimed to explore patients’ and their 
families’ experiences of how this worked in practice. It 
was conducted in two acute hospital settings in the East of 
England where dementia case finding was implemented 
with little or no evaluation of its effectiveness in terms 
of improving patient outcomes. To our knowledge, this 
is the first study to explore the views and experiences of 
older patients and their family carers to case finding and 
to estimate the economic impact for the health service.
We spoke to patients and carers of patients who had 
been identified as having a concern about their cognition 
Table 4 Quotes illustrating theme 2
Quote Patients’ and carers’ follow-up experiences
16 Well I mean, I’m a bit surprised that the GP hasn’t been to see 
her. (Carer 01)
17 I don’t feel the GP’s that interested. (Carer 16)
18 I did, I prompted it. So how did you prompt it, what happened?
Alright, I… I told the GP that she needs this test. (Carer 06)
19 No, that was me … [raised wife’s memory after unrelated GP 
visit] That was a good while ago and he’s never mentioned 
anything since. (Carer 20)
20 I’d asked his GP if he could have a psychiatric assessment 
and they sent round a CPN and she chatted to him and she 
said to me ‘oh yes, he has got dementia’, she said ‘I’m not 
quite sure what type, I’ll discuss it with the team’ because the 
consultant was away at that time ‘and we’ll let you know’. Well 
she never did get back to me. (Carer 16)
21 so why is it not dealt with in the hospital when they’re actually 
there, and they can see there’s a problem. (Carer 02)
22 I think it works well, like I said, it works well too that I’ve kind 
of got a bit of my life back…it definitely helps having carers 
three times a day. (Carer 02)
23 We could not have managed without it. We were getting 
desperate—we could not manage, we couldn’t be there for 
long enough. (Carer 14)
24 It’s not care, they just come in, write a bit in her folder and that 
is it, that is not care, they do not look after my mum. (Carer 05)
25 they come at so weird times. I mean, for instance, the other 
Sunday night they came at twenty past five to put her to bed. 
Have you ever heard of anything so stupid! (Carer 01)
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during their hospital admission. Although the median 
MMSE score of included participants at interview indi-
cated that most patients had mild cognitive impairment, 
MMSE scores ranged from 6 to 30. The findings from 
this study suggest that there was little follow-up from 
patients’ GPs postdischarge and few further investigations 
or referrals or medication instigated due to dementia 
case finding outcomes; although in some cases, patients 
had already been seen by their GP prior to their hospital 
stay about their cognition. The lack of follow-up may not 
be surprising in light of the fact the outcomes of dementia 
case finding are often poorly reported to GPs.27
Patients and their families had mixed attitudes towards 
dementia case finding but many did not remember the 
assessment and/or did not appear to have been informed 
about what this would mean in terms of their subsequent 
care and treatment. There was also concern that the acute 
hospital setting might not be the best place in which to 
assess cognition. Indeed, 10 former patients had MMSE 
scores which indicated no cognitive impairment despite 
having been picked up by the case finding process when in 
hospital. In a previous paper, we reported that dementia 
case finding has raised awareness about dementia within 
hospitals.27 However, delirium is often undetected in 
hospitals40 and can increase the likelihood of reporting 
false positives and result in misdiagnosis of dementia.41
The results of the costing evaluation showed that partic-
ipants/patients had average costs of £5180. The mean 
length of time over which these costs were incurred was 
283 days, excluding the initial stay. Although these individ-
uals had been identified from dementia case finding, the 
proportion of those costs attributed directly to services 
related to cognition appear to be small (~6%). This is 
not surprising as we found that few services had been 
instigated due to case finding. While the costs of services 
initiated in the community following case finding did not 
appear to be high, from health professionals’ reports of 
how case finding has been implemented in the previous 
phase of the CASCADE study27 it is likely that case finding 
is associated with significant costs within the hospital 
itself, though to our knowledge no research to date has 
quantified these yet. This suggests that an evaluation of 
the costs of such a policy, including the opportunity costs 
within the policy implementations system (Public Health 
England, NHS England) are warranted.
limitations
The small sample size and the reliance on participants’ 
self-reporting are limitations of the study. Recruiting in 
this setting is challenging and only a small proportion of 
those who have experienced hospital case finding could 
be consulted for the study and may not be representa-
tive of the patient group even within the single settings. 
Patients found it difficult to correctly recall services 
received and the reason for those services. Therefore, 
it was difficult to judge whether services received were a 
direct consequence of dementia case finding. Carers were 
responsible for coordinating their relative’s care and 
consequently carers were able to provide more informa-
tion than patients. The participants in this study may not 
be representative of others elsewhere in the UK, although 
no other such study has taken place to our knowledge. 
Since presentation of our findings to key policy makers 
the mandatory nature and financial incentives associated 
with dementia case finding are no longer in place. The 
study remains relevant as moves to promote case finding 
across health settings affect many countries and it serves 
as an illustration of the vital need to test policies before 
implementing them on the large scale.42 43
COnClusIOns
This study highlights that dementia case finding in hospi-
tals did not necessarily lead to a GP follow-up or referrals 
for further investigation or lead to new supportive services 
being put in place. Often patients and their family carers 
were not informed that memory assessments had been 
carried out while in hospital or what the outcomes of the 
assessment would mean in terms of their future care and 
treatment. There is a need for a more evidence-based 
approach to the initiation of mandatory initiatives such as 
case finding. This includes evaluation of the costs of such 
a policy, including the opportunity costs within the policy 
implementations system.
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